Physician profile
Justin E Mallit
NPI 1801141163
$1,281.63
in general payments reported to CMS, 2019-2025
20 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $757 · 2022: $476 · 2023: $48.83.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $48.83.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $48.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $207.75 | 2021-2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $158.85 | 2021 | |
| Electronic Waveform Lab, INC. | $115.49 | 2022 | |
| Collegium Pharmaceutical, INC. | $91.30 | 2021 | |
| Boston Scientific Corporation | $89.69 | 2021-2023 | |
| Tersera Therapeutics LLC | $82.16 | 2022 | |
| Ibsa Pharma INC. | $69.50 | 2021 | |
| Eisai INC. | $64.84 | 2021 | |
| Hikma Pharmaceuticals USA | $60.73 | 2021-2022 | |
| Arbor Pharmaceuticals, INC. | $59.38 | 2021-2022 | |
| Teva Pharmaceuticals USA, INC. | $52.57 | 2021 | |
| Painteq LLC | $46.05 | 2021-2022 | |
| Pacira Therapeutics, INC. | $41.38 | 2021 | |
| Abbvie INC. | $28.52 | 2021 | |
| Almatica Pharma LLC | $27.00 | 2021 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Spinal Simplicity, LLC | $24.98 | 2022 | |
| Biohaven Pharmaceuticals, INC. | $23.65 | 2021 | |
| Amgen INC. | $17.79 | 2022 | |
| Virtus Pharmaceuticals LLC | $14.31 | 2021 | |
| Mml US, INC. | $5.69 | 2022 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Justin Mallit listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.